Staphylococcus lugdunensis infective endocarditis: a multicentre international observational study.
Benjamin Lefevre, Gilbert Habib, Bruno Hoen...
https://pubmed.ncbi.nlm.nih.gov/40952378/Actively Recruiting
Led by Central Hospital, Nancy, France · Updated on 2025-09-23
5000
Participants Needed
1
Research Sites
52 weeks
Total Duration
This research aims to create a national database of infective endocarditis by collecting detailed information from volunteer medical centers across the country. It focuses on describing the clinical, microbiological, therapeutic, and progression aspects of infective endocarditis, analyzing risk factors and prognosis, and comparing real-world drug and surgical treatments. Data collected includes clinical characteristics such as heart disease history, symptoms, and complications biological and microbiological details like microorganism identification and antibiotic sensitivity echocardiographic features and treatment details including antibiotic and surgical interventions. All information is recorded using standardized electronic case report forms by physicians during patient hospitalization. Participants will have their medical history, biological markers, imaging, and treatment data collected and monitored throughout hospitalization. Researchers will evaluate factors like heart disease history, infection origin, clinical symptoms, biological and microbiological outcomes, imaging results, and treatments from inclusion to recovery. Optional biological sample collection may also occur. The study is ongoing with data collected since 1991, led by Central Hospital, Nancy, France.
CONDITIONS
French National Observatory on Infective Endocarditis
N
Nadine JUGE, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Central Hospital, Nancy, France
Lead Sponsor
Bichat Hospital
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - From inclusion to recovery
Participants undergo diagnostic assessments including clinical, biological, microbiological, and imaging evaluations to describe the history and characteristics of infective endocarditis.
Duration - From inclusion to recovery
Participants are observed during hospitalization to monitor the evolution of infective endocarditis including therapeutic management and outcomes.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Benjamin Lefevre, Gilbert Habib, Bruno Hoen...
https://pubmed.ncbi.nlm.nih.gov/40952378/L Bucy, M L Erpelding, C Boursier...
https://pubmed.ncbi.nlm.nih.gov/37524996/Guillaume Béraud, Sarah Tubiana, Marie-Line Erpelding...
https://pubmed.ncbi.nlm.nih.gov/35618954/Guillaume De Ciancio, Marie-Line Erpelding, Laura Filippetti...
https://pubmed.ncbi.nlm.nih.gov/34742672/Christine Selton-Suty, François Delahaye, Pierre Tattevin...
https://pubmed.ncbi.nlm.nih.gov/27400273/Yohan N'Guyen, Xavier Duval, Matthieu Revest...
https://pubmed.ncbi.nlm.nih.gov/27607562/Magali Collonnaz, Marie-Line Erpelding, François Alla...
https://pubmed.ncbi.nlm.nih.gov/33225027/Francois Goehringer, Benoit Lalloué, Christine Selton-Suty...
https://pubmed.ncbi.nlm.nih.gov/38330171/Christine Selton-Suty, François Goehringer, Clément Venner...
https://pubmed.ncbi.nlm.nih.gov/31056233/Safwane El Hatimi, Marie-Line Erpelding, Christine Selton-Suty...
https://pubmed.ncbi.nlm.nih.gov/38175782/Central Hospital, Nancy, France
Lead Sponsor
Bichat Hospital
Collaborating Sponsor